Product Reports Resources Pricing Login Book a demo

Turbine AI

Biotech & Life Sciences · Budapest, Hungary · Founded 2016

Simulation-driven drug discovery company delivering population targeted cancer therapies MoreLess

Turbine AI has developed a cell simulation platform that uses machine learning to model human biology and predict the effectiveness of cancer treatments. This technology, called Simulated Cells™, aims to improve the drug discovery and development process by identifying promising therapeutic targets and patient populations that are most likely to respond to treatment.

The company collaborates with pharmaceutical companies, such as AstraZeneca, to apply its simulation platform to specific challenges in oncology, like understanding drug resistance in hematological cancers. By simulating how cancer cells behave at a molecular level, Turbine AI can provide insights that are difficult to obtain through traditional laboratory experiments alone.

The platform is designed to de-risk drug development, potentially reducing the time and cost associated with bringing new therapies to market. The company offers a "Virtual Lab" for potential clients to explore the technology's capabilities.

Keywords: cell simulation, oncology, drug discovery, machine learning, personalized medicine, cancer treatment, R&D, biotechnology, pharmaceutical, hematology

Valuation $0–100M
Revenue $1–10M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Turbine AI and the history behind them.

Company overview

Turbine AI company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2016
Headquarters
Budapest, Hungary
Employees
116
Open positions
3
Dealroom signal
86.0
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyDeep TechtechnologyMachine Learningsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorDrug DevelopmentsectorBiomarkerssectorNeurology

Valuation & funding

Turbine AI funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Feb 2026 $23M $93M Beiersdorf · Accel · Mercia Asset Management · MSD Global Health Innovation Fund
LATE VCOther financing May 2024 $0 Accenture Ventures
SERIES AOther financing Jun 2023 $6M $110M MassMutual Ventures
SERIES AOther financing Nov 2022 $22M $88M Accel · Day One Capital · Mercia Asset Management · Merck & Co.
SEEDOther financing Jan 2021 $6.3M $25M Boston Millennia Partners · Atlantic · O2h Ventures · Delin Ventures
SUPPORT PROGRAMOther financing Jun 2020 EIT Health
LATE VCOther financing Feb 2020 O2h Ventures · AI Fund
SEEDOther financing Nov 2019 Atlantic · Esther Dyson · Delin Ventures · O2h Ventures
ANGELOther financing Jan 2017 Atlantic
SPINOUTOther financing Sep 2013 Budapest University of Technology and Economics
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $7.3M 0% 116
2025 $7.3M +1.5% 103
2024 $7.2M +43% 100
2023 $5.1M +47.4% 90
2022 $3.4M +50.7% 71
2021 $2.3M +8.2% 60
2020 $2.1M 55
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Turbine AI website traffic

Latest recorded traffic for Turbine AI is 10K monthly website visits, up 0% over the last three months. Turbine AI's team grew 12.6% over the past year.

Latest monthly visits10K 3-month web change0% 1-year team growth+12.6%
Monthly website visits114 observations · Dec 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Turbine AI compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Turbine AI's talent

Book a demo to see the people
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

18 investors on Turbine AI's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 6 investors entered at this stage
Atlantic
Delin Ventures
Esther Dyson
O2h Ventures
Accel
Boston Millennia Partners
Series A 8 investors entered at this stage
Day One Capital
Mercia Asset Management
Merck & Co.
XTX Ventures
MassMutual Ventures
Interactive Venture Partners
Beiersdorf
MSD Global Health Innovation Fund
Series B+ 2 investors entered at this stage
AI Fund
Accenture Ventures
Other known 2 additional known investors
Budapest University of Technology and Economics
EIT Health

Global footprint

Where Turbine AI has talent and traffic

Workforce by country
13 countries with
team presence
🇭🇺 Hungary70.2%
🇬🇧 United Kingdom7.5%
🇺🇸 United States5.3%
🇪🇸 Spain4.3%
🇦🇹 Austria2.1%
Top 5 of 13 shown

In the news

Latest news about Turbine AI

Recent press, funding announcements, and product moves mentioning Turbine AI — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Turbine AI

An AI-synthesized read of the highest-engagement posts about Turbine AI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Turbine AI’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.